univalent vaccine【药】 - PMC

Result Filters

You searched 8+ million full text articles

Try this search in 34+ million citations and abstracts

PMC Full-Text Search Results

Items: 1 to 20 of 605

<< First< Prev

Page of 31

Next >Last >>

Select item 106741961.

Advancing Vaccine Strategies against Candida Infections: Exploring New Frontiers

Gurpreet Kaur, Sonam Chawla, Piyush Kumar, Ritu Singh

Vaccines (Basel) 2023 Nov; 11(11): 1658. Published online 2023 Oct 29. doi: 10.3390/vaccines11111658

PMCID:: PMC10674196

Article PDF–1.0M

Select item 89409822.

Advances in COVID-19 mRNA vaccine development

Enyue Fang, Xiaohui Liu, Miao Li, Zelun Zhang, Lifang Song, Baiyu Zhu, Xiaohong Wu, Jingjing Liu, Danhua Zhao, Yuhua Li

Signal Transduct Target Ther. 2022; 7: 94. Published online 2022 Mar 23. doi: 10.1038/s41392-022-00950-y

PMCID:: PMC8940982

Article PDF–4.2M

Select item 96378713.

Advancing mRNA technologies for therapies and vaccines: An African context

Dylan Kairuz, Nazia Samudh, Abdullah Ely, Patrick Arbuthnot, Kristie Bloom

Front Immunol. 2022; 13: 1018961. Published online 2022 Oct 24. doi: 10.3389/fimmu.2022.1018961

PMCID:: PMC9637871

Article PDF–2.9M

Select item 52271694.

Mucosal Vaccine Development Based on Liposome Technology

Valentina Bernasconi, Karin Norling, Marta Bally, Fredrik Höök, Nils Y. Lycke

J Immunol Res. 2016; 2016: 5482087. Published online 2016 Dec 29. doi: 10.1155/2016/5482087

PMCID:: PMC5227169

Article PDF–1.9M

Select item 93397835.

Evaluation of Brucellosis Vaccines: A Comprehensive Review

Mohsen Heidary, Shirin Dashtbin, Roya Ghanavati, Marzie Mahdizade Ari, Narjess Bostanghadiri, Atieh Darbandi, Tahereh Navidifar, Malihe Talebi

Front Vet Sci. 2022; 9: 925773. Published online 2022 Jul 18. doi: 10.3389/fvets.2022.925773

PMCID:: PMC9339783

Article PDF–483K

Select item 54451086.

Antigen-Sparing and Enhanced Efficacy of Multivalent Vaccines Adjuvanted with Immunopotentiators in Chickens

Peipei Wu, Jihu Lu, Lei Feng, Hongzhuan Wu, Xuehua Zhang, Mei Mei, Jibo Hou, Xiufan Liu, Yinghua Tang

Front Microbiol. 2017; 8: 927. Published online 2017 May 26. doi: 10.3389/fmicb.2017.00927

PMCID:: PMC5445108

Article PDF–4.3M

Select item 89528557.

Nasal Nanovaccines for SARS-CoV-2 to Address COVID-19

Jialu Huang, Yubo Ding, Jingwei Yao, Minghui Zhang, Yu Zhang, Zhuoyi Xie, Jianhong Zuo

Vaccines (Basel) 2022 Mar; 10(3): 405. Published online 2022 Mar 8. doi: 10.3390/vaccines10030405

PMCID:: PMC8952855

Article PDF–1.6M

Select item 74640658.

SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic

Ali A. Rabaan, Shamsah H. Al-Ahmed, Ranjit Sah, Ruchi Tiwari, Mohd. Iqbal Yatoo, Shailesh Kumar Patel, Mamta Pathak, Yashpal Singh Malik, Kuldeep Dhama, Karam Pal Singh, D. Katterine Bonilla-Aldana, Shafiul Haque, Dayron F. Martinez-Pulgarin, Alfonso J. Rodriguez-Morales, Hakan Leblebicioglu

Ann Clin Microbiol Antimicrob. 2020; 19: 40. Published online 2020 Sep 2. doi: 10.1186/s12941-020-00384-w

PMCID:: PMC7464065

Article PDF–2.0M

Select item 49947429.

Multifunctional particle-constituted microneedle arrays as cutaneous or mucosal vaccine adjuvant-delivery systems

Xueting Wang, Ning Wang, Ning Li, Yuanyuan Zhen, Ting Wang

Hum Vaccin Immunother. 2016 Aug; 12(8): 2075–2089. Published online 2016 May 9. doi: 10.1080/21645515.2016.1158368

PMCID:: PMC4994742

Article PDF–1.3M

Select item 562724710.

Escherichia coli-derived virus-like particles in vaccine development

Xiaofen Huang, Xin Wang, Jun Zhang, Ningshao Xia, Qinjian Zhao

NPJ Vaccines. 2017; 2: 3. Published online 2017 Feb 9. doi: 10.1038/s41541-017-0006-8

PMCID:: PMC5627247

Article PDF–1.4M

Select item 991840611.

Vaccines for prion diseases: a realistic goal?

Scott Napper, Hermann M. Schatzl

Cell Tissue Res. 2023; 392(1): 367–392. Published online 2023 Feb 11. doi: 10.1007/s00441-023-03749-7

PMCID:: PMC9918406

Article PDF–1.5M

Select item 511573512.

A Rapid-Response Humoral Vaccine Platform Exploiting Pre-Existing Non-Cognate Populations of Anti-Vaccine or Anti-Viral CD4+ T Helper Cells to Confirm B Cell Activation

Thomas Hills, Phillip G. Jakeman, Robert C. Carlisle, Paul Klenerman, Leonard W. Seymour, Ryan Cawood

PLoS One. 2016; 11(11): e0166383. Published online 2016 Nov 18. doi: 10.1371/journal.pone.0166383

PMCID:: PMC5115735

Article PDF–2.0M

Select item 1003408513.

Immunogenicity and protective efficacy of OmpA subunit vaccine against Aeromonas hydrophila infection in Megalobrama amblycephala: An effective alternative to the inactivated vaccine

Minying Zhang, Ting Zhang, Yang He, Hujun Cui, Hong Li, Zehua Xu, Xu Wang, Yunlong Liu, Hongping Li, Xiaoheng Zhao, Hanliang Cheng, Jianhe Xu, Xiangning Chen, Zhujin Ding

Front Immunol. 2023; 14: 1133742. Published online 2023 Mar 9. doi: 10.3389/fimmu.2023.1133742

PMCID:: PMC10034085

Article PDF–6.6M

Select item 840247914.

DNA Vaccine Administered by Cationic Lipoplexes or by In Vivo Electroporation Induces Comparable Antibody Responses against SARS-CoV-2 in Mice

Allegra Peletta, Eakachai Prompetchara, Kittipan Tharakhet, Papatsara Kaewpang, Supranee Buranapraditkun, Teerasit Techawiwattanaboon, Tayeb Jbilou, Pratomporn Krangvichian, Sunee Sirivichayakul, Suwimon Manopwisedjaroen, Arunee Thitithanyanont, Kanitha Patarakul, Kiat Ruxrungtham, Chutitorn Ketloy, Gerrit Borchard

Vaccines (Basel) 2021 Aug; 9(8): 874. Published online 2021 Aug 6. doi: 10.3390/vaccines9080874